REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Lekaren 20, S. R. O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Direct Selling Establishments
Full name: Lekaren 20, S. R. O. Profile Updated: July 13, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Lekaren 20, S. R. O. is based in Slovakia. The head office is in Kosice. It operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on January 23, 2009. Lekaren 20, S. R. O. currently employs 5 - 9 (2025) people. The latest financial highlights indicate a net sales revenue increase of 10.34% in 2024. Its’ total assets recorded a growth of 6.4%. The net profit margin of Lekaren 20, S. R. O. decreased by 1.15% in 2024.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Lekaren 20, S. R. O. report to view the information.

Basic Information
Total Employees:
Purchase the Lekaren 20, S. R. O. report to view the information.
Registered Capital:
Purchase the Lekaren 20, S. R. O. report to view the information.
Financial Auditors:
Purchase the Lekaren 20, S. R. O. report to view the information.
Incorporation Date:
January 23, 2009
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Lekaren 20, S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
10.34%▲
Total operating revenue
10.34%▲
Operating profit (EBIT)
-53.78%▼
EBITDA
-56.84%▼
Net Profit (Loss) for the Period
-46.96%▼
Total assets
6.4%▲
Total equity
7.96%▲
Operating Profit Margin (ROS)
-1.42%▼
Net Profit Margin
-1.15%▼
Return on Equity (ROE)
-7.64%▼
Debt to Equity Ratio
-0.22%▼
Quick Ratio
0.01%▲

Similar companies

Dr.Max 100 S.R.O.
 
Lekaren Rpt, S. R. O.
Benu Sk 77, S. R. O.
 
Lekaren Arcus, S.R.O.
Unizdrav Presov, S.R.O.
 
Z&T Pharma S.R.O.
Alexifarm S.R.O.
 
Medimed S. R. O.
Avaler S. R. O.
 
Dr.Max 23 S.R.O.
Farmasab, Spol. S R. O.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo